entity

AD risk

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AD risk: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
2Hypotheses
5Analyses
0Outgoing
4Incoming
0Experiments
6Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (4)

SourceRelationTypeStr
APOE4risk_factor_forgene0.90
APOEε4risk_factor_forgene0.90
TREM2associated_withgene0.90
PLCG2associated_withgene0.90

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Female microglia exhibit heightened complement gene expressi 0.610 neurodegeneration Synaptic pruning by microglia in neurode
Ethnic and Metabolic Epigenetic Clock Divergence Explains Di 0.474 - Epigenetic clocks as biomarkers for Alzh

Mentioning Analyses (5)

Scientific analyses that reference this entity

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 0 hypotheses

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.591

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619

How does APOE4's beneficial immune function reconcile with its established role

neurodegeneration | 2026-04-12 | 0 hypotheses

APOE4 targeting in neurodegeneration

neurodegeneration | 2026-04-02 | 4 hypotheses Top: 0.720

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (15)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Epigenetic/circadian clocks and PCOS. [PMID:38600622] Vatier C, Christin-Maitre S Hum Reprod 2024 0
The role of cellular senescence in neurodegenerative diseases. [PMID:38744709] Wang Y, Kuca K, You L, Nepovimova E, Heg Archives of toxicology 2024 0
The role of cellular senescence in neurodegenerative diseases. [PMID:38744709] Wang Y, Kuca K, You L, Nepovimova E, Heg Archives of toxicology 2024 0
Exercise therapy to prevent and treat Alzheimer's disease. [PMID:37600508] ["Pahlavani H"] Frontiers in aging neuroscienc 2023 0
Exercise therapy to prevent and treat Alzheimer's disease. [PMID:37600508] ["Pahlavani H"] Frontiers in aging neuroscienc 2023 0
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. [PMID:34239348] Zhang, Wei, Zhao, Ma, Jiang et al. International journal of biolo 2022 0
Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive dec [PMID:35130907] ["Liu Sen", "Fan Min", "Xu Jing-Xian", " Journal of neuroinflammation 2022 0
Metabolic programs tailor T cell immunity in viral infection, cancer, and aging. [PMID:35235773] Møller SH, Hsueh PC, Yu YR Cell Metab 2022 0
Epigenetic clock: A promising biomarker and practical tool in aging. [PMID:36206857] Duan R, Fu Q, Sun Y Ageing Res Rev 2022 0
DNA methylation GrimAge version 2. [PMID:36516495] Lu AT, Binder AM, Zhang J Aging (Albany NY) 2022 0
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. [PMID:34239348] Unknown International journal of biolo 2022 0
Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive dec [PMID:35130907] ["Liu Sen", "Fan Min", "Xu Jing-Xian", " Journal of neuroinflammation 2022 0
A systematic review of biological, social and environmental factors associated w [PMID:33930583] Oblak L, van der Zaag J, Higgins-Chen AT Ageing Res Rev 2021 0
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer [PMID:34116706] Sun XY, Li LJ, Dong QX, Zhu J, Huang YR, Journal of neuroinflammation 2021 0
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer [PMID:34116706] Sun XY, Li LJ, Dong QX, Zhu J, Huang YR, Journal of neuroinflammation 2021 0

Debates (6)

Multi-agent debates referencing this entity

What are effective therapeutic strategies for targeting APOE4 in Alzheimer's dis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

What is the current clinical trial landscape for AD therapeutics, and which mech

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Is the amyloid concentration in AD clinical trials rational given lecanemab's ap

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The abstract shows TYROBP deficiency is neuroprotective despite being required f

closed · Rounds: 4 · Score: 0.56 · 2026-04-15

The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mi

closed · Rounds: 4 · Score: 0.60 · 2026-04-15

How does APOE4's beneficial immune function reconcile with its established role

closed · Rounds: 4 · Score: 0.78 · 2026-04-12

Related Research

Hypotheses and analyses mentioning AD risk in their description or question text

No additional research found